eHealth Q3 Revenue Falls 60% to $21.3M; FY26 Guidance Reiterated
EHTH sits 43% above its 52-week low of $0.454 on elevated volume (3.1× avg).
Summary
eHealth's Q3 revenue fell 60% to $21.3 million on deliberately reduced marketing, producing a $35.9 million net loss but 85% better year-to-date operating cash flow of $19.6 million. Full-year guidance was reiterated.
Key Events · Earnings and Guidance · EHTH
-
Q3 Revenue Down 60% to $21.3M
Total revenue fell to $21.3 million from $53.9 million a year ago, in line with the strategy of cutting variable marketing outside major enrollment periods.
-
Loss Widens; Tail Revenue Collapses
GAAP net loss was $35.9 million versus $31.7 million, and adjusted EBITDA was $(39.9) million versus $(34.0) million. Positive net adjustment revenue dropped to $1.4 million from $12.2 million.
-
Cash Flow Improves 85% Year to Date
Q3 operating cash flow improved $14.1 million year-over-year to $(11.2) million; the first nine months generated $19.6 million versus $10.6 million. Cash, equivalents and short-term marketable securities totaled $88.1 million.
-
FY26 Guidance Reiterated
Revenue $405-445 million, GAAP net income $8-25 million, adjusted EBITDA $55-75 million, operating cash flow $(10)-12 million; positive net adjustment revenue narrowed to $17-20 million from $16-20 million.
Analysis · EHTH · Finance
The 60% year-over-year revenue collapse to $21.3 million is deliberate: eHealth pulled variable marketing spend outside enrollment periods, cutting total operating costs 29% and marketing 55%. Even so, the quarter produced a $35.9 million GAAP net loss and $(39.9) million adjusted EBITDA, worse than a year ago, mainly because tail revenue from prior-year members shrank to $1.4 million from $12.2 million. Cash is the offsetting positive. Q3 operating cash flow improved $14.1 million year-over-year, and the first nine months generated $19.6 million, up 85%, leaving $88.1 million in cash and securities against a $115.5 million long-term debt balance. Management reiterated full-year guidance of $405-445 million revenue and $55-75 million adjusted EBITDA, so the thesis now rests on whether the annual enrollment period delivers. Against that backdrop, the previously disclosed Nasdaq minimum-bid notice (stock at $0.65) keeps a reverse split and potential delisting on the table.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.2% of the 2649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EHTH was trading at $0.65 on NASDAQ in the Finance sector, with a market capitalization of approximately $20.3M. The 52-week trading range was $0.45 to $5.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.